Cullen/Frost Bankers, Inc. Boston Scientific Corp Transaction History

Cullen/Frost Bankers, Inc.

$8.43 Billion
Q3 2025

A detailed history of Cullen/Frost Bankers, Inc. transactions in Boston Scientific Corp stock. As of the latest transaction made, Cullen/Frost Bankers, Inc. holds 355,369 shares of BSX stock, worth $36.5 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares

355,369

Previous 361,002 1.56%

Holding current value

$36.5 Million

Previous $38.8 Million 10.52%

% of portfolio

0.41%

Previous 0.5%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 31, 2025	SELL	$97.03 - $108.14 $546,569 - $609,152	-5,633 Reduced 1.56%	355,369 $34.7 Million
Q2 2025 Jul 30, 2025	BUY	$89.7 - $107.41 $18,209 - $21,804	203 Added 0.06%	361,002 $38.8 Million
Q1 2025 May 02, 2025	SELL	$89.38 - $106.18 $310,595 - $368,975	-3,475 Reduced 0.95%	360,799 $36.4 Million
Q4 2024 Feb 06, 2025	SELL	$83.62 - $91.5 $426,294 - $466,467	-5,098 Reduced 1.38%	364,274 $32.5 Million
Q3 2024 Nov 06, 2024	BUY	$72.96 - $84.0 $432,215 - $497,616	5,924 Added 1.63%	369,372 $31 Million
Q2 2024 Aug 05, 2024	BUY	$67.33 - $77.71 $819,810 - $946,196	12,176 Added 3.47%	363,448 $28 Million
Q1 2024 May 10, 2024	SELL	$57.6 - $68.62 $669,657 - $797,776	-11,626 Reduced 3.2%	351,272 $24.1 Million
Q4 2023 Feb 06, 2024	SELL	$48.64 - $57.81 $290,429 - $345,183	-5,971 Reduced 1.62%	362,898 $21 Million
Q3 2023 Nov 02, 2023	BUY	$50.19 - $54.68 $39,700 - $43,251	791 Added 0.21%	368,869 $19.5 Million
Q2 2023 Aug 04, 2023	SELL	$49.72 - $54.64 $119,775 - $131,627	-2,409 Reduced 0.65%	368,078 $19.9 Million
Q1 2023 May 05, 2023	BUY	$45.09 - $50.03 $162,639 - $180,458	3,607 Added 0.98%	370,487 $18.5 Million
Q4 2022 Feb 13, 2023	BUY	$39.56 - $47.22 $364,387 - $434,943	9,211 Added 2.58%	366,880 $17 Million
Q3 2022 Nov 07, 2022	SELL	$36.71 - $109.66 $2.49 Million - $7.44 Million	-67,837 Reduced 15.94%	357,669 $13.9 Million
Q2 2022 Aug 05, 2022	SELL	$35.24 - $47.1 $201,008 - $268,658	-5,704 Reduced 1.32%	425,506 $15.9 Million
Q1 2022 May 09, 2022	BUY	$40.9 - $45.1 $157,178 - $173,319	3,843 Added 0.9%	431,210 $19.1 Million
Q4 2021 Feb 07, 2022	SELL	$38.07 - $44.87 $1.24 Million - $1.46 Million	-32,582 Reduced 7.08%	427,367 $18.2 Million
Q3 2021 Nov 04, 2021	SELL	$41.23 - $45.88 $2.28 Million - $2.54 Million	-55,416 Reduced 10.75%	459,949 $20 Million
Q2 2021 Aug 05, 2021	BUY	$38.58 - $44.24 $336,919 - $386,347	8,733 Added 1.72%	515,365 $22 Million
Q1 2021 May 05, 2021	SELL	$35.27 - $39.67 $1.22 Million - $1.37 Million	-34,487 Reduced 6.37%	506,632 $19.6 Million
Q4 2020 Feb 08, 2021	SELL	$33.15 - $41.97 $601,771 - $761,881	-18,153 Reduced 3.25%	541,119 $19.5 Million
Q3 2020 Nov 05, 2020	BUY	$34.44 - $42.23 $494,007 - $605,747	14,344 Added 2.63%	559,272 $21.4 Million
Q2 2020 Aug 05, 2020	BUY	$30.19 - $39.11 $3.06 Million - $3.96 Million	101,258 Added 22.82%	544,928 $19.1 Million
Q1 2020 May 01, 2020	BUY	$25.83 - $45.71 $559,503 - $990,124	21,661 Added 5.13%	443,670 $14.5 Million
Q4 2019 Feb 06, 2020	BUY	$37.87 - $45.37 $419,448 - $502,518	11,076 Added 2.7%	422,009 $19.1 Million
Q3 2019 Nov 01, 2019	BUY	$40.31 - $43.45 $125,243 - $134,999	3,107 Added 0.76%	410,933 $16.7 Million
Q2 2019 Aug 01, 2019	BUY	$34.91 - $42.98 $3.17 Million - $3.91 Million	90,900 Added 28.68%	407,826 $17.5 Million
Q1 2019 Apr 30, 2019	BUY	$32.91 - $40.75 $1.08 Million - $1.34 Million	32,761 Added 11.53%	316,926 $12.2 Million
Q4 2018 Feb 06, 2019	BUY	$31.73 - $39.04 $9.02 Million - $11.1 Million	284,165 New	284,165 $10 Million

Others Institutions Holding BSX

# of Institutions

1,950

Shares Held

1.26B

Call Options Held

10.9M

Put Options Held

8.94M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $147B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cullen/Frost Bankers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cullen/Frost Bankers, Inc. with notifications on news.

Account

Cullen/Frost Bankers, Inc. Boston Scientific Corp Transaction History